Results 11 to 20 of about 381,122 (317)

Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients

Avicenna Journal of Medicine, 2023
Pneumocystis jirovecii pneumonia is an opportunistic fungal infection that was mainly associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) disease.
Atif Ibrahim, Asmi Chattaraj, Qamar Iqbal, Ali Anjum, Mohammad Ebad Ur Rehman, Zobia Aijaz, Fazila Nasir, Sadia Ansar, Tirdad T. Zangeneh, Ahmad Iftikhar   +9 more
doaj   +2 more sources

Development and Evaluation of Rapid and Accurate CRISPR/Cas13-Based RNA Diagnostics for Pneumocystis jirovecii Pneumonia

Frontiers in Cellular and Infection Microbiology, 2022
BackgroundPneumocystis jirovecii can result in a serious pulmonary infection, Pneumocystis jirovecii pneumonia, in immunocompetent hosts. The diagnosis of Pneumocystis jirovecii pneumonia has long been a major clinical concern, and there are limitations ...
Yangqing Zhan, Xiaoqing Gao, Shaoqiang Li, Yeqi Si, Yuanxiang Li, Xu Han, Wenjun Sun, Zhengtu Li, Feng Ye   +8 more
doaj   +2 more sources

Pneumocystis Pneumonia

Journal of the Formosan Medical Association, 2008
Pneumocystis pneumonia (PcP) in humans is caused by Pneumocystis jirovecii, which has recently been reclassified as a fungus because its cell wall composition and nucleotide sequences are more similar to those of fungi.
Jang-Jih Lu, Chao-Hung Lee
doaj   +4 more sources

Lung Injury in COVID-19 and Pneumocystis Pneumonia. Similarities and Differences

Туберкулез и болезни лёгких, 2022
In the regions with the high prevalence of HIV infection, it is necessary to perform differential diagnosis of lung injury caused by COVID-19 and pneumocystis pneumonia.The main complaints in COVID-19 and pneumocystis pneumonia are similar and include ...
E. A. Borodulina, E. S. Vdoushkina, E. V. Yakovleva   +2 more
doaj   +1 more source

Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments

Pathogens, 2021
For individuals who are immunocompromised, the opportunistic fungal pathogen Pneumocystis jirovecii is capable of causing life-threatening pneumonia as the causative agent of Pneumocystis pneumonia (PCP). PCP remains an acquired immunodeficiency disease (
Aaron D. Gingerich, K. Norris, J. Mousa
semanticscholar   +1 more source

Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG

Critical Care, 2023
Background Pneumocystis jirovecii pneumonia (PJP) is an opportunistic, life-threatening disease commonly affecting immunocompromised patients. The distribution of predisposing diseases or conditions in critically ill patients admitted to intensive care ...
D. Giacobbe, S. Dettori, V. di Pilato, E. Asperges, L. Ball, E. Berti, O. Blennow, B. Bruzzone, L. Calvet, Federico Capra Marzani, Antonio Casabella, Sofia Choudaly, Anais Dartevel, G. De Pascale, Gabriele Di Meco, Melissa Fallon, L. Galerneau, M. Gallego, M. Giacomini, Adolfo González Sáez, Luise Hänsel, G. Icardi, P. Koehler, K. Lagrou, T. Lahmer, P. Lewis White, L. Magnasco, A. Marchese, C. Marelli, M. Marín-Arriaza, I. Martín-Loeches, A. Mekontso-Dessap, M. Mikulska, A. Mularoni, A. Nordlander, J. Poissy, Giovanna Russelli, A. Signori, C. Tascini, Louis-Maxime Vaconsin, J. Vargas, A. Vena, J. Wauters, P. Pelosi, J. Timsit, M. Bassetti, Matteo Mario Chiara Denise Iole Filippo Sara Sofía Marice Cerchiaro Zaccarelli Robba Battaglini Brunetti Del, Matteo Cerchiaro, Mario Zaccarelli, C. Robba, D. Battaglini, I. Brunetti, F. Del Puente, Sara Mora, S. de la Villa, M. Valerio, Patricia Muñoz, G. Lombardi, Melania Cesarano, Veronica Gennenzi, P. Meersseman, G. Hermans, A. Wilmer, K. Razazi, G. Carteaux, N. de Prost, O. Cornely, D. Seidel, A. Alastruey‐Izquierdo, J. Garcia Borrega, C. Bonnal, E. de Montmollin, Julien Dessajan, M. Ceresini, F. Mojoli, A. Vola, C. Garnaud, E. Díaz, O. Gasch, E. Prina, S. Rasch, Miriam Dibos, Stefan Haschka   +82 more
semanticscholar   +1 more source

The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia

Journal of Fungi, 2022
Pneumocystis jiroveci remains an important fungal pathogen in immunocompromised hosts. The environmental reservoir remains unknown. Pneumonia (PJP) results from airborne transmission, including in nosocomial clusters, or with reactivation after an ...
A. Apostolopoulou, J. Fishman
semanticscholar   +1 more source

Differences and similarities of high-resolution computed tomography features between pneumocystis pneumonia and cytomegalovirus pneumonia in AIDS patients

Infectious Diseases of Poverty, 2020
Background Accurately differentiating pneumocystis from cytomegalovirus pneumonia is crucial for correct therapy selection in AIDS patients. Hence, the goal of this study was to compare the computerized tomography (CT) features of pneumocystis pneumonia ...
Chun-Jing Du, Jing-Yuan Liu, Hui Chen, Shuo Yan, Lin Pu, Hao-Feng Xiong, Pan Xiang, Chuan-Sheng Li, Ming Zhang, Ru-Ming Xie, Bu-Dong Chen, Ang Li   +11 more
doaj   +1 more source

Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina

Pathogens, 2021
Pneumocystis jirovecii is a fungal pathogen that can cause life-threatening infections in individuals who are immunocompromised. Acquired via inhalation, upon entering the respiratory tract, the fungi first encounter innate immune cells such as alveolar ...
Theodore J. Kottom, Kyle Schaefbauer, Eva M. Carmona, Andrew H. Limper   +3 more
doaj   +1 more source

Case Report: Successful treatment of severe pneumocystis carinii pneumonia in a case series of primary nephrotic syndrome after receiving anti-CD20 monoclonal antibody therapy

Frontiers in Pediatrics, 2023
Rituximab is emerging as a new steroid sparing agent in children with difficult-to-treat nephrotic syndrome due to its ability of depleting CD20-positive B cells.
Lili Liu, Weihua Zheng, Ping Wang, Ying Wu, Guanghua Zhu, Rong Yang, Li Gu, Wenyan Huang, Yulin Kang   +8 more
doaj   +1 more source